TYGRIS - ROW: TYSABRI® Global Observational Program in Safety - Rest of World
The TYSABRI® Global Observational Program in Safety for Rest of World (TYGRIS - ROW)is a
safety observational cohort program designed to obtain long-term safety data in MS patients
treated with TYSABRI® in a clinical practice setting in countries other than the United
States and Canada.
The Prescribing Physician will collect patient information at routine clinic visits (using
standard data collection tools) at approximately 6-month intervals for 5 years from the
first TYSABRI® infusion.
Observational Model: Cohort, Time Perspective: Prospective
Germany: Federal Institute for Drugs and Medical Devices